CDC’s Key Role in Global Programs to Stop HIV NO LONGER EXISTS
Trump Administration Cuts CDC’s Key Role in Global Program to Stop HIV
As of May 2026, the Trump administration has effectively terminated the CDC's leading role in global HIV care, with State Department guidance ending CDC support for the PEPFAR program in most countries by September 30. This move disrupts the 23-year-old President’s Emergency Plan for AIDS Relief, which previously relied on the CDC for expertise and funding in 46 recipient nations, threatening to dismantle global HIV treatment and prevention. [1]
Key Impacts of the Cut:
- PEPFAR Restructuring: The State Department, which oversees PEPFAR, has instructed that it is now up to each country whether to continue utilizing the CDC for HIV work.
- Budget and Personnel: The administration has cut CDC staff and proposed a 40% reduction in PEPFAR’s bilateral HIV funding for FY26.
- Loss of Expertise: The move eliminates crucial CDC technical assistance, with observers warning this effectively dismantles the foundational structure of the U.S. global HIV response.
- Domestic and Global Consequences: Beyond global cuts, the administration has also targeted domestic HIV prevention, terminating $600 million in CDC grants and proposing to cut domestic HIV care, prevention, and surveillance by $1.5 billion. [1, 2, 3, 4]
Context for the Changes:
- Administration Rationale: Officials defend the actions as a budget realignment and a move to change how foreign aid is handled, with critics labeling the shift a "final blow" to the success of PEPFAR.
- Broader Health Cuts: The administration is simultaneously cutting global tuberculosis funding by 56%, malaria funding by 47%, and maternal/child health funding by 93%.
- Global Health Impact: Public health experts warn that pulling the CDC from global HIV efforts will not only destroy decades of progress in HIV, but will also hinder the ability to detect and respond to other infectious diseases like Ebola and Mpox. [1, 2, 3, 4, 5]
The move has generated significant criticism from health officials, who argue it undermines a highly successful, bipartisan, and lifesaver initiative, according to reports from Science and KFF. [1, 2, 3, 4]
2. https://onlinelibrary.wiley.com/doi/10.1111/aji.70224?af=R
5. https://onlinelibrary.wiley.com/doi/10.1111/aji.70224?af=R